Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon-Seng Khoo, Robyn Mary Brown
CNS DRUGS | ADIS INT LTD | Published : 2014
RMB and SYK are supported by the National Health and Medical Research Council of Australia. SYK is supported by an Australian Postgraduate Award; RMB is supported by a Peter Doherty Fellowship. The authors declare that they have no conflicts of interest.